MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement